You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
About Kedrion - Front Image

Investor Relations

A 570 million euros’ turnover with a 22,3% rise on 2014, international sales accounting for 74% of the overall turnover, a 20,8% adjusted EBITDA, a net profit of 38,7 million euros: here are the key figures of 2015’s statement of accounts for Kedrion SpA, approved on 29th April 2016 by the Shareholders’ Meeting.

The company showed its usual bent for expansion on the global markets in 2015 as well, above all in the United States where it exceeded 250 million euros this year (+59% vs 2014).